Lupin's Phase IV Report for Glycopyrronium, Vilanterol Inhalation Gets CDSCO Panel Nod Parthika Patel3 Dec 2025 5:02 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has accepted the Phase IV clinical trial...
Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes Susmita Roy2 Dec 2025 10:22 PM ISTNew Delhi: Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...
CDSCO Panel Approves Akums' Proposal to Manufacture, Market Nitisinone Dispersible Tablets for Hereditary Tyrosinemia Type 1 Susmita Roy30 Nov 2025 4:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended granting...
Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme Susmita Roy29 Nov 2025 10:37 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval for...
DCC Flags State-Level Gaps, Calls for Nationwide Uniform Enforcement of Drug Quality Standards Susmita Roy29 Nov 2025 10:34 PM ISTNew Delhi: Aiming to tighten the nationwide oversight of drug quality, the Drugs Consultative Committee (DCC) has urged the Centre to address the...
CDSCO Panel Clears Bristol Myers' Yervoy for Two New Cancer Indications Susmita Roy28 Nov 2025 9:09 PM ISTNew Delhi: In a significant regulatory development for cancer care in India, the Subject Expert Committee functioning under the Central Drugs Standard...
CDSCO Panel Directs Mankind Pharma to Conduct Phase I Trial of Sintilimab Before Phase III Launch Susmita Roy27 Nov 2025 10:48 PM ISTNew Delhi: The Subject Expert Committee functioning under the Central Drugs Standard Control Organisation (CDSCO) has opined Mankind Pharma should...
State Drug Alert: 148 Medicine Samples Fail CDSCO Quality Tests in October Susmita Roy27 Nov 2025 10:23 PM ISTNew Delhi: Reflecting persistent drug quality concerns in India's pharmaceutical market, the Central Drugs Standard Control Organisation (CDSCO) has...
Intas Pharma Gets CDSCO Panel Nod to Conduct Phase I Trial of Pertuzumab, Trastuzumab Solution for Injection Susmita Roy26 Nov 2025 6:32 PM ISTNew Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Intas...
CDSCO Flags 5 Batches of Widely Used Drugs Including Azithral-500, Telma-AM as Potentially Spurious Susmita Roy25 Nov 2025 9:57 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has flagged five widely used medicines, including Azithral-500, Telma-AM, Noophin,...
Johnson and Johnson Told to Justify Phase III Icotrokinra Trial Design Over Sample Size, Patient Exposure Parthika Patel25 Nov 2025 5:48 PM ISTNew Delhi: Johnson & Johnson Pvt. Ltd. (JnJ) has been asked to justify key aspects of its proposed Phase III clinical trial protocol for...
Sun Pharma Gets CDSCO Panel Nod to Conduct Active Post-Marketing Study for Antacid Combination Tablet Parthika Patel24 Nov 2025 6:58 PM ISTNew Delhi: Sun Pharma Laboratories Limited has received clearance from the Subject Expert Committee (SEC), under the Central Drugs Standard Control...
